Basit öğe kaydını göster

dc.contributor.authorTariq, M. Umer
dc.contributor.authorGibson, C. Michael
dc.contributor.authorPride, Yuri B.
dc.contributor.authorWiviott, Stephen D.
dc.contributor.authorBuros, Jacqueline L.
dc.contributor.authorZorkun, Cafer
dc.contributor.authorBraunwald, Eugene
dc.contributor.authorAntman, Elliott M.
dc.date.accessioned2022-02-18T11:22:35Z
dc.date.available2022-02-18T11:22:35Z
dc.date.issued2009
dc.identifier.citationPride Y. B. , Wiviott S. D. , Buros J. L. , Zorkun C., Tariq M. U. , Antman E. M. , Braunwald E., Gibson C. M. , "Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: A TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 Substudy", AMERICAN HEART JOURNAL, cilt.158, sa.3, 2009
dc.identifier.issn0002-8703
dc.identifier.otherav_efd067ef-d57a-498a-992a-2ced90d85785
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/181055
dc.identifier.urihttps://doi.org/10.1016/j.ahj.2009.06.021
dc.description.abstractBackground Prasugrel led to a significant reduction in ischemic cardiovascular events among patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PC]) with stent implantation compared to clopidogrel. Whether this benefit extends to patients undergoing PCI without stent implantation is unknown.
dc.language.isoeng
dc.subjectCARDIAC ve CARDIOVASCULAR SİSTEMLER
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectKardiyoloji
dc.subjectCardiology and Cardiovascular Medicine
dc.subjectHealth Sciences
dc.titleEffect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: A TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 Substudy
dc.typeMakale
dc.relation.journalAMERICAN HEART JOURNAL
dc.contributor.departmentHarvard University , ,
dc.identifier.volume158
dc.identifier.issue3
dc.contributor.firstauthorID3377065


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster